19 May 2009: Zhang B, Chang J, Fu M, Huang J, Kashyap R, et al. (2009) Correction: Dosage Effects of Cohesin Regulatory Factor PDS5 on Mammalian Development: Implications for Cohesinopathies. PLOS ONE 4(5): 10.1371/annotation/ea5b7eb5-5087-448a-8325-c8efff1f54d9. https://doi.org/10.1371/annotation/ea5b7eb5-5087-448a-8325-c8efff1f54d9 View correction
Cornelia de Lange syndrome (CdLS), a disorder caused by mutations in cohesion proteins, is characterized by multisystem developmental abnormalities. PDS5, a cohesion protein, is important for proper chromosome segregation in lower organisms and has two homologues in vertebrates (PDS5A and PDS5B). Pds5B mutant mice have developmental abnormalities resembling CdLS; however the role of Pds5A in mammals and the association of PDS5 proteins with CdLS are unknown. To delineate genetic interactions between Pds5A and Pds5B and explore mechanisms underlying phenotypic variability, we generated Pds5A-deficient mice. Curiously, these mice exhibit multiple abnormalities that were previously observed in Pds5B-deficient mice, including cleft palate, skeletal patterning defects, growth retardation, congenital heart defects and delayed migration of enteric neuron precursors. They also frequently display renal agenesis, an abnormality not observed in Pds5B−/− mice. While Pds5A−/− and Pds5B−/− mice die at birth, embryos harboring 3 mutant Pds5 alleles die between E11.5 and E12.5 most likely of heart failure, indicating that total Pds5 gene dosage is critical for normal development. In addition, characterization of these compound homozygous-heterozygous mice revealed a severe abnormality in lens formation that does not occur in either Pds5A−/− or Pds5B−/− mice. We further identified a functional missense mutation (R1292Q) in the PDS5B DNA-binding domain in a familial case of CdLS, in which affected individuals also develop megacolon. This study shows that PDS5A and PDS5B functions other than those involving chromosomal dynamics are important for normal development, highlights the sensitivity of key developmental processes on PDS5 signaling, and provides mechanistic insights into how PDS5 mutations may lead to CdLS.
Citation: Zhang B, Chang J, Fu M, Huang J, Kashyap R, Salavaggione E, et al. (2009) Dosage Effects of Cohesin Regulatory Factor PDS5 on Mammalian Development: Implications for Cohesinopathies. PLoS ONE 4(5): e5232. https://doi.org/10.1371/journal.pone.0005232
Editor: Ellen A. A. Nollen, University Medical Center Groningen, Netherlands
Received: January 6, 2009; Accepted: March 6, 2009; Published: May 1, 2009
Copyright: © 2009 Zhang et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by NIH Neuroscience Blueprint Center Core Grant P30 NS057105 to Washington University, the HOPE Center for Neurological Disorders, and NIH grants CA111966 and AG13730 (J.M.), HD047396 (S.J.), DK57038 and DK6459201 (R.O.H.), EY04853 (D.C.B.), and Washington University Cancer Biology Pathway Fellowship (B.Z.). P.Y.J. is a Scholar of the Child Health Research Center of Excellence in Developmental Biology at Washington University School of Medicine (HD001487). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Cornelia de Lange syndrome (CdLS; OMIM #122470) is a rare developmental disorder (∼1∶10,000) characterized by mental retardation, myopia, growth retardation, congenital heart defects, intestinal anomalies, facial dysmorphisms including cleft palate and appendicular skeletal malformations . A breakthrough in the understanding of CdLS occurred when mutations in the NIPBL gene were identified in ∼50% of CdLS patients , . NIPBL protein is required for cohesin, a protein complex that mediates sister chromatid cohesion, to bind to chromosomes. More recently, mutations in SMC1A and SMC3, core components of cohesin, have been identified in CdLS patients , indicating that cohesin dysfunction is the basis of the anomalies associated with CdLS. In addition, mutations in ESCO2, a protein acetyltransferase required for sister chromatid cohesion, have been identified in Robert's syndrome (RBS; OMIM # 268300), a developmental disorder with similarities to CdLS , . Most CdLS cases are sporadic (>99%), but some show an autosomal dominant ,  or X-linked recessive pattern of inheritance with variable expressivity or incomplete penetrance . Interestingly, the abnormalities of affected individuals that share the same mutation even within families can vary widely –. The mechanistic basis of variability in phenotypic expressivity and penetrance in CdLS are unknown but are thought to involve modifier genes, epigenetic factors or environmental influences .
Cohesin is a highly conserved multi-protein complex required for sister chromatid cohesion, a process that ensures accurate chromosomal segregation during cell division. The cohesin complex consists of the core components, SMC1, SMC3, SCC1(RAD21) and SCC3 (SA), and is regulated by the associated factors, PDS5 (PDS5A and PDS5B in mammals), WAPL, SCC2 (NIPBL), SCC4 (MAU-2), ECO1 (ESCO1 and ESCO2 in mammals) and Separase –. In addition to chromosomal dynamics, cohesin and its regulatory factors play important roles in development by regulating cell movement and axonal outgrowth in C. elegans , , transcriptional regulation of neurodevelopmental regulators in Zebrafish , and control of long-range gene expression in Drosophila . Most recently, the non-mitotic functions of cohesin and cohesin-associated proteins have been highlighted by their high expression in post-mitotic neurons in adult mice , , the neuronal deficits in Pds5B-deficient mice , and the discovery that Drosophila mutants in SMC1, RAD21, and SA have defects in axonal pruning and dendritic targeting , . These studies, coupled with the identification of causative mutations in cohesin components in human developmental syndromes, promise to shed new light on the non-canonical functions of cohesin and cohesin-associated proteins during development.
While early work in Drosophila indicated that Nipped-B (NIPBL, SCC2) is important for regulating long-range gene expression of the cut locus , the role of cohesin in transcription has been difficult to decipher. A recent genome-wide study in Drosophila showed that Nipped-B and cohesin bind to the transcribed and regulatory regions of many active developmental genes , providing further evidence for cohesin-mediated transcriptional regulation. ChIP-on-Chip analysis of cohesin binding sites across the human genome and 3% of the mouse genome revealed that cohesin is bound to chromatin at ∼9,000 sites and, that most of these sites overlap with binding sites for the chromatin insulator protein CTCF , . The co-localization of cohesin and CTCF suggests that a possible molecular mechanism underlying developmental disorders caused by cohesin component mutations is the aberrant regulation of gene expression. The molecular features of CTCF (a transcriptional insulator) and cohesin, which topologically encircles chromosomes , suggest that together they may regulate gene expression through control of global nuclear dynamics, such as interchromosomal or intrachromosomal looping. The contribution of cohesin to CTCF-mediated insulator activity  could account for the variability in phenotypic expressivity and penetrance observed in CdLS.
The molecular functions of PDS5A and PDS5B in mammals are largely unknown, but their homologues in lower organisms are required for sister chromatid cohesion and interact genetically and/or physically with cohesin core components and its accessory factors . In fungi, PDS5 antagonizes the establishment of cohesion until counteracted by ECO1  and is acetylated by ECO1 in vitro . PDS5A and PDS5B are very similar except for the addition of two AT-hook motifs at the carboxy terminus of PDS5B. PDS5A and PDS5B both interact with WAPL, a cohesin-associated protein that regulates dissociation of cohesin from chromatin .
Previously, we generated and characterized Pds5B-deficient mice and found that they die at birth with a constellation of abnormalities reminiscent of those observed in patients with CdLS . The high frequency of mental retardation and behavioral disorders in CdLS suggests that cohesin abnormalities lead to neuronal dysfunction. In accord, we found high expression of PDS5B in post-mitotic neurons as well as deficits in neuronal migration and axonal projection in Pds5B-deficient mice. We also noted the absence of sister chromatid cohesion deficits in cells from these mice, again consistent with findings in CdLS patients. Overall, these observations indicate that cohesin proteins have multiple roles that together shape the development of multi-cellular organisms.
Similar to human CdLS, Pds5B mutant mice exhibit variable expressivity of phenotypes, but unlike human CdLS, Pds5B mutant mice do not have diaphragmatic hernia or eye or kidney abnormalities, which are associated with CdLS. It is possible that Pds5A may have compensated for Pds5B loss or these defects may be dependent solely on Pds5A activity or require marked reduction in total PDS5 activity. To explain the variable expressivity observed in Pds5B-deficient mice and CdLS cases, we hypothesized that Pds5A may be partially compensating for Pds5B loss. To this end, we generated and characterized Pds5A-deficient mice and found that they manifest multiple developmental defects. Many of the abnormalities are similar to those present in CdLS patients and Pds5B-deficient mice, suggesting functional redundancy between PDS5A and PDS5B in embryonic development. The CdLS-like developmental anomalies in Pds5A, B-deficient mice along with the involvement of PDS5A and PDS5B in the same molecular complex as NIPBL, SMC1A, SMC3, prompted us to explore whether PDS5A and PDS5B mutations are associated with CdLS. We sequenced the PDS5A and PDS5B gene from genomic DNAs of NIPBL and SMC1A mutation negative CdLS patients and identified a missense mutation (R1292Q) that disrupts PDS5B DNA-binding and likely causes or contributes to a familial case of CdLS. These findings provide strong evidence that the functions of PDS5 proteins and associated cohesin are crucial for normal mammalian development.
Pds5A deficiency results in developmental abnormalities similar to those present in Pds5B mutant mice
Because Pds5B mutant mice exhibit phenotypic variability and incomplete penetrance , we hypothesized that Pds5A might partially compensate for mutant Pds5B function. To test this hypothesis and to determine the role of Pds5A, we generated Pds5A-deficient mice using ES cells with an insertion of the β-geo transgene in the second intron (Baygenomics genetrap line RRM243, See Fig. S1 in Supplementary Data and Materials S1). Quantitative RT-PCR analysis revealed universal expression of both Pds5A and Pds5B during embryonic development (See Fig. S2 in Supplementary Data and Materials S1). In adulthood, Pds5A is expressed at similarly low levels in all tissues (See Fig. S3A in Supplementary Data and Materials S1), whereas adult expression of Pds5B is more variable between tissues, with particularly high levels observed in adult testis and brain . Using the Pds5A-deficient mice, we also examined the Pds5A expression pattern using X-gal histochemistry to detect the mutant Pds5A-β-galactosidase fusion protein created by gene trap. We detected expression of β-galactosidase in most tissues, including the nervous system where Purkinje cells in the cerebellum and neurons in the cerebral cortex and retina had strong X-gal staining (See Fig. S3 in Supplementary Data and Materials S1). We also found high Pds5A mRNA and protein levels in cultured dorsal root ganglia and hippocampal neurons, supporting the idea that PDS5 proteins play important roles in post-mitotic neurons (data not shown).
To determine the impact of Pds5A loss during development we bred heterozygous Pds5A animals to obtain Pds5A null animals. We found that Pds5A-deficient mice die perinatally, and are significantly smaller than their wildtype and Pds5A-heterozygous littermates (Fig. 1A), even though no overt structural abnormalities were observed (Fig. 1B). To examine the skeleton, we stained newborn pups with Alcian Blue and Alizarin Red S to highlight the cartilage and bones. We detected several defects with incomplete penetrance and variable expressivity including cleft palate (20/61 in Pds5A−/−, 4/77 in Pds5A+/−, 0/39 in Pds5A+/+; Fig. 1C–F), presence of cervical ribs (10/10 in Pds5A−/−, 0/11 in Pds5A+/+; fusion of C7 and T1 or transformation of C7 to T1; Fig. 1G–J), abnormal sternum (5/10 in Pds5A−/−, 0/25 in Pds5A+/+; Fig. 1K–N) and abnormal patterns of vertebral ossification (17/26 in Pds5A−/−, 0/7 in Pds5A+/−, 0/3 in Pds5A+/+; Fig. 1O, P). Many of these defects were similar to those observed in Pds5B mutant mice, indicating that both PDS5 proteins have important roles in skeletal patterning and palatogenesis. Interestingly, both mouse mutants had variable penetrance and expressivity of these skeletal defects suggesting that total Pds5 dosage is critical for palatogenesis and skeletal patterning. The importance of Pds5 dosage is further highlighted by the frequency of cleft palate, which is 33% (20/61) in Pds5A homozygotes and 5% (4/77) in Pds5A heterozygotes, a finding consistent with the idea that reduced dosage of functional cohesin results in the developmental anomalies characteristic of CdLS.
(A) The weight of Pds5A−/− P0 mice is significantly lower than that of wildtype and heterozygous littermates (WT, n = 8; Pds5A+/−, n = 30; Pds5A−/−, n = 39). Error bars represent s.e.m. *P<0.001, Student's unpaired, two tailed t-test. (B) Morphology of wildtype and Pds5A mutant mice. Note that newborn Pds5A−/− pups (right) were smaller than their wildtype littermates (left). Note too the absence of milk in the stomach of the Pds5A−/− pup. Scale bar: 0.5 cm. (C, D) Alizarin Red S and Alcian Blue staining of neonatal skulls demonstrates complete cleft palate (arrows) of a Pds5A−/− neonate (D) compared with the proximity of palatal bones in the midline (arrow) in the wildtype control (C). Scale bar: 0.5 mm. (E, F) Palatogenesis defects illustrated using H&E stained coronal sections of E18.5 wildtype (E) and Pds5A−/− (F) embryos. ps, palatal shelf; n, nasal bone; t, tongue. Arrows in F point to the unfused palatal shelves. Scale bar: 1 mm. (G–P) Alizarin Red S and Alcian Blue staining of newborn skeleton. Bone is stained red and cartilage is stained blue. (G–J) Cervical and thoracic vertebrae and ribs. Note the C7-T1 fusions (arrows in H, I) and cervical rib (arrow in J) in Pds5A−/− mice, compared to the normal skeletal patterning in wildtype animals (G). Cervical (C) and Thoracic (T) vertebrae are marked by numbers. (K–N) Sternum morphology. Arrows denote ectopic rib-sternum conjunctions (L–N) in Pds5A−/− mice compared to sternum patterning in wildtype (K). (O, P) Morphology of the first cervical vertebrae. Note the unfused ossification centers at the dorsal tip of the first cervical vertebrae (arrows) in Pds5A−/− animal (P) compared to wildtype (O). Scale bar for G–N: 1 mm; scale bar for O–P: 0.5 mm. (Q, R) Renal abnormalities in neonatal Pds5A-deficient mice. (Q) Bilateral renal agenesis in Pds5A−/− newborn animals. AG, adrenal gland. Scale bar: 1 mm. (R) The total number of glomeruli in kidneys from P0 Pds5A−/− and wildtype mice were counted (n = 4 animals, 8 kidneys). (*, P<0.05, student unpaired t test; mean±s.e.m.).
Renal anomalies are also associated with CdLS  and PDS5A has been implicated in renal growth . These reports and the high renal expression of Pds5A in newborn and adult mice (See Fig. S3A, F in Supplementary Data and Materials S1) prompted us to examine renal development in Pds5A-deficient mice. We found that ∼13% (8/61) of Pds5A-deficient mice have either unilateral or bilateral kidney agenesis (Fig. 1Q). Furthermore, when kidneys do develop in these mutant mice, they are hypoplastic and have a reduced number of glomeruli (Fig. 1R). The defects in embryonic renal development could contribute to the perinatal lethality of the Pds5A-deficient animals.
Pds5A-mutant mice have normal sympathetic neuronal projections and germ cell differentiation
Cohesin components are crucial for axonal projection and neuronal migration in mice (PDS5B) , axonal pruning and dendritic targeting in Drosophila (SMC1, RAD21, and SA) , , axonal guidance in C. elegans (MAU-2/SCC4) , and nervous system development in zebrafish (SMC1, RAD21) . The expression of Pds5A in post-mitotic neurons (See Fig. S3 in Supplementary Data and Materials S1), the role of other cohesin components in neuronal development and function, and the mental retardation and behavioral abnormalities associated with CdLS, encouraged us to examine the nervous system in Pds5A−/− mice. Consistent with the largely normal brain anatomy observed in CdLS patients and in Pds5B-deficient mice, we did not observe any gross or microscopic structural anomalies in Pds5A−/− brain. Cultured hippocampal neuron developed normally (data not shown) with no obvious defects in survival or polarity (Fig. 2A and B). These data suggest that PDS5A does not play obvious roles in embryonic central nervous system development.
(A, B) Hippocampal neurons from wildtype and Pds5A mutant mice were cultured for 3 days and stained with TuJ1 antibody. The neurons show normal axonal projection and polarity (one axon per neuron). Arrowheads, cell bodies; arrows, axons. (C, D) Tyrosine hydroxylase (TOH) whole-mount staining of sympathetic projections from the superior cervical ganglion in wildtype (C) and Pds5A mutant (D) mice showed that the carotid nerves (indicated by arrows) project normally to the eye. ey, eye; ea, ear. (E, F) H&E staining of germ cells in neonatal testes showed similar numbers of germ cells in wildtype (E) and Pds5A−/− (F) mice. Arrows point to testicular cords surrounding the germ cells. (G, H) H&E staining of 6-week testes transplants of E18.5 wildtype (G) and Pds5A−/− mice (H). Note the presence of elongated spermatids with condensed heads and long tails in both wildtype and Pds5A−/− testis explants (arrows).
The defects in sympathetic innervation emanating from the superior cervical ganglion (SCG) observed in Pds5B-deficient mice could explain the ptosis frequently associated with CdLS . In contrast to Pds5B-deficient mice, the sympathetic nervous system in Pds5A−/− mice was unremarkable, with a well developed SCG that was positioned appropriately and had normally appearing neuronal projections (Fig. 2C and D).
Pds5B-deficient mice have severe depletion of primordial germ cells in the testes and ovaries and some cases of CdLS also exhibit significant reduction or absence of germ cells , . An examination of Pds5A−/− mice revealed normal germ cell development with similar numbers of germ cells in both the testes and ovaries of wildtype and Pds5A−/− P0 mice (Fig. 2E and F; See Fig. S4 in Supplementary Data and Materials S1). To further examine whether PDS5A might regulate sister chromatid cohesion during meiosis, a histological analysis of gonadal germ cells in P0 female mice was performed. We found that most germ cells in both Pds5A-deficient and wildtype ovaries demonstrated the distinctive nuclear morphology with condensed chromosomes that characterize the zygotene and pachytene stages of meiotic prophase (See Fig. S4A, B in Supplementary Data and Materials S1). We also examined spermatogenesis, using testicular transplantation  to propagate E18.5 testis as explants on the backs of nude mice. We found similar numbers of spermatogonia and round spermatids in wildtype and Pds5A mutant transplanted testes 4 weeks after transplantation (n = 4; See Fig. S4C,D in Supplementary Data and Materials S1). By 6 weeks after transplantation, the explanted Pds5A−/− testes contained testicular cords with the full spectrum of spermatogenesis (n = 5; Fig. 2 G, H), including mature spermatids with condensed heads and elongated tails (See Fig. S4E,F in Supplementary Data and Materials S1). Together, these data indicated that Pds5A is not required for meiosis or primordial germ cell development.
Pds5 gene dosage affects mouse embryonic development: phenotypic defects in Pds5A+/−; Pds5B−/− mice and Pds5A−/−;Pds5B+/− mice
Pds5B-deficient cells do not display defects in chromosome cohesion, suggesting that the developmental abnormalities in Pds5B mutant mice arise from the lack of other, non-canonical PDS5B functions . To test for cohesion defects in Pds5A-deficient cells, we obtained MEF lines (n = 3) from Pds5A-deficient and wildtype embryos. Both Pds5A-deficient and wildtype MEFs proliferate at the same rate (data not shown), and the levels of the cohesin components SMC3 (Fig. 3A) and SCC1 in these cells were equivalent (data not shown). We performed metaphase chromosome analysis by GTG (giemsa-banding using trypsin and giemsa) banding of these mutant MEFs. We analyzed >50 metaphase cells per line and found no obvious cohesion defects such as precocious sister chromatid separation (PSCS) or gross chromosomal abnormalities in Pds5A−/− MEFs (data not shown). The lack of sister chromatid cohesion abnormalities in cells lacking either PDS5A or PDS5B suggests that they have redundant functions in sister chromatid cohesion and that their roles in mammalian embryonic development are unlikely to be related to their role in cohesion.
(A) Overall cohesin levels in E14.5 kidney lysates were assessed by Western blotting using anti-SMC3 antibodies. ß-tubulin levels were used to confirm equivalent protein loading. Note that SMC3 levels were equivalent in tissues from wildtype and Pds5A−/− mice. (B) GTG (giemsa-banding using trypsin and giemsa) banded metaphase spreads from mouse embryonic fibroblasts (MEFs) derived from wildtype and Pds5A−/−;Pds5B+/− mice showed no evidence of precocious sister chromatid separation (PSCS). (C) Fluorescent Recovery After Photobleaching (FRAP) using SCC1-EGFP in wildtype and Pds5A−/−;Pds5B+/− MEFs. Half of the nucleus was bleached and fluorescence intensity was measured every 30 sec for 30 min. The images show the recovery dynamics over time. Note no significant difference of cohesin recovery dynamics between wildtype and Pds5A−/−;Pds5B+/− cells after photobleaching. (D) A summary table listing the abnormalities associated with Pds5 deficiencies demonstrates the genetic interactions between Pds5A and Pds5B. The left diagram displays the age when most embryos of the indicated genotype died. The right table lists the phenotypes observed in the indicated embryos. Hom, homozygote; het, heterozygote; wt, wild type; GD, growth delay; CP, cleft palate; SPD, skeletal patterning defects; CHD, congenital heart defects; PNSD, peripheral nervous system defects; LD, lens development defects; PGCD, primordial germ cell defects; CD, cohesion defects; KD, kidney developmental defects. +, presence of the indicated phenotype; - absence of the indicated phenotype; ND, not determined; N/A, not applicable since no embryos were obtained for double homozygous mutants. *, Pds5A homozygotes have delayed ENS precursor migration, but normal SCG projection. [+], highlights functional redundancy and diversification of PDS5A and PDS5B.
The phenotypic overlap between Pds5A- and Pds5B-deficient mice also suggests the possibility of redundant functions between these two closely related homologs during development. To study the effects of PDS5 dosage on sister chromatid cohesion and embryonic development, we crossed Pds5A+/− with Pds5B+/− to obtain compound heterozygotes. These were then used to generate double homozygous or compound homozygous-heterozygous mice (i.e. mice with only one wild type Pds5 allele, either Pds5A or Pds5B). No Pds5A−/−;Pds5B−/− double homozygous embryos were obtained at E9.5 (Fig. 3D), indicating that depletion of both Pds5A and Pds5B leads to very early embryonic lethality. However, Pds5A+/−;Pds5B−/− and Pds5A−/−;Pds5B+/− embryos were identified, but had severe growth retardation and died between E11.5 and E12.5. The phenotype of these mutant embryos clearly demonstrated the redundant effects of PDS5A and PDS5B on heart, enteric nervous system, and lens development (Fig. 3D).
To ascertain whether low levels of PDS5 proteins can affect sister chromatid cohesion, cohesin stability or cohesin chromosome-binding dynamics, we studied MEFs prepared from Pds5A−/−;Pds5B+/− and Pds5A+/−;Pds5B−/− embryos. The analysis of metaphase spreads of these MEFs did not show any abnormalities in sister chromatid cohesion (Fig. 3B). We then used fluorescence recovery after photobleaching (FRAP) assays to compare the dynamics of association of a SCC1-EGFP fusion protein with chromosomes in mutant and wildtype MEFs. We found that fluorescence recovery dynamics of SCC1-EGFP in wildtype, Pds5A−/−;Pds5B+/−, and Pds5A+/−;Pds5B−/− MEFs all showed similar slow recovery curves (Fig. 3C; See Fig. S5A in Supplementary Data and Materials S1) with a time scale consistent with previous reports . We also found no significant differences in residence times of either weak or strong chromatin-bound SCC1-EGFP between wildtype and Pds5 mutant MEFs (See Fig. S5B in Supplementary Data and Materials S1). There is a similar composition of soluble SCC1-EGFP as well as weak and strong chromatin-bound SCC1-EGFP proteins between wildtype and Pds5 mutant MEFs (See Fig. S5C in Supplementary Data and Materials S1) was also observed. These results indicate that cells with only one Pds5 wildtype allele (either Pds5A or Pds5B) have normal cohesin stability and cohesin-chromatin association dynamics and imply that embryonic development is more sensitive than sister chromatid cohesion to levels of PDS5 activity.
Both PDS5A and PDS5B are important for cardiac development
Congenital heart defects (CDH), primarily atrial septal defects, are frequently observed in children with CdLS (range 14–70% in different studies) . Similar types of CHDs are present in Pds5B−/− mice . Pds5A−/− mice suffer from respiratory distress and die within a few hours after birth, suggesting that they may also have cardiac anomalies. Indeed, we found that Pds5A−/− mice, compared to wildtype mice, had significantly higher incidence of congenital heart defects (17/25 versus 3/18, P<0.001; Fig. 4A–D, See Table S1 in Supplementary Data and Materials S1), including those that are commonly found in CdLS patients  and Pds5B-deficient mice .
(A) A section of a wildtype mouse heart demonstrates the intact ventricular septum and its relationship to the aortic and tricuspid valves.. (B–D) Sections of Pds5A mutant hearts showing: (B) a perimembranous ventricular septal defect (VSD); (C) the pulmonary valve and artery in a heart with double outlet right ventricle; (D) the aorta arising from the right ventricle of the same heart with a muscular conus between the aortic and mitral valve (arrowhead). Arrows indicate the respective defects. Scale bar: 0.5 mm. (E–J) Severe cardiac defects in Pds5A+/−;Pds5B−/− and Pds5A−/−;Pds5B+/− embryos. (E) A section from wildtype E12.5 embryonic heart shows the separation of aorta and pulmonary artery and the developing aortic valves (arrow). (F) A Pds5A−/−;Pds5B+/− E12.5 embryonic heart shows the underdeveloped endocardial cushion of the outflow tract and the non-septated aorta and pulmonary artery (i.e., truncus arteriosus). (G) Normal association of the atrial and ventricular septae with the endocardiac cushion and valve morphogenesis in a wildtype E12.5 heart. (H) A Pds5A+/−;Pds5B−/− E12.5 heart demonstrates the dilated atria and underdeveloped endocardial cushion with no valve formation, and failure of atrioventricular canal septation. (I) Wildtype E12.5 heart with a compact myocardial layer of normal thickness. (J) A Pds5A−/−;Pds5B+/− heart has a thin compact myocardium. Double-headed arrows in (I, J) indicate the compact myocardial layer. Ao, aorta; PA, pulmonary artery; RA, right atrium; LA, left atrium; RV, right ventricle; LV, left ventricle; EC, endocardial cushion; T, trabecular myocardium; C, compact myocardium.
In Pds5A−/− mice, we identified atrial septal defect of the secundum type (ASD, 1/25), isolated ventricular septal defects (VSDs, 10/25; all perimembranous), double outlet right ventricle (DORV, 1/25), and atrioventricular canal defects (AVCDs, 5/25) (Fig. 4A–D; See Table S1 in Supplementary Data and Materials S1). All of these defects, except for ASD, would be expected to cause excessive pulmonary circulation and edema from left-to-right shunting of blood at the ventricular level, thus resulting in respiratory distress and potentially contributing to the early postnatal lethality.
Heterozygous Pds5A mice (5/19) also had heart defects that were more severe than those in wildtype littermates. For instance, we identified Pds5A heterozygotes with tetralogy of Fallot (TOF, a common malformation in CdLS, which was also associated with an ASD; 1/19), ASD alone (3/19), or VSD (1/19) (See Table S1 in Supplementary Data and Materials S1).
Interestingly, we identified small VSDs in 3/18 wildtype littermates derived from Pds5A heterozygote breedings. This is significantly higher than seen in wild-type controls in other mouse models of congenital heart disease (<1%; Jay PY, unpublished observations). This observation suggests that parental Pds5A heterozygosity could adversely affect the genetic stability of gametes, perhaps by causing aneuploidy or epigenetic changes that increase the frequency of developmental defects in the progeny. This hypothesis is supported by the recent evidence that maternal CTCF, whose function may be mediated via cohesin complexes , , is essential for proper oocyte meiosis and embryonic development .
The high expression of both Pds5A and Pds5B in the embryonic heart along with the presence of cardiac defects in both Pds5A- and Pds5B-deficient mice emphasizes the crucial function of PDS5 activity in cardiac development. To further explore the consequences of PDS5 loss in the heart, we examined Pds5A−/−;Pds5B+/− or Pds5A+/−;Pds5B−/− E12.5 embryos. All embryos lacking three Pds5 alleles (n = 4) had severe cardiac abnormalities including truncus arteriosus (TA) and a common atrioventricular canal. The endocardial cushions of the outflow tract failed to develop separate aortic and pulmonic valve leaflets, and the aorticopulmonary septum was absent (Fig. 4E, F). An underlying defect in neural crest-derived cell migration likely contributes to these abnormalities of outflow tract development . The common atrioventricular canal defect was marked by severe hypoplasia or aplasia of the ventricular septum and a failure of valve development from the atrioventricular canal cushion tissue (Fig. 4G, H). Furthermore, all Pds5A−/−;Pds5B+/− or Pds5A+/−;Pds5B−/− embryos had a thin compact ventricular myocardium and dilated atria (Fig. 4I, J). The absence of competent atrioventricular valves likely causes atrial dilation due to regurgitant blood flow. In combination with a thin, dysfunctional myocardium, forward cardiac output would be severely compromised, leading to growth retardation and embryonic lethality.
Synergistic effects of PDS5A and PDS5B on enteric nervous system (ENS) development
Pds5B-deficient mice have severe ENS defects, including delayed enteric neuron precursor migration and distal colon aganglionosis . To assess the contribution of PDS5A to ENS development, we performed whole mount staining of Pds5A−/− fetal gut using TuJ1 antibody, a marker for enteric neurons. By E12.5, enteric neurons had colonized the entire small bowel and half of the colon in wildtype embryos. In contrast, in Pds5A−/− mice, ENS precursors had failed to migrate much beyond the ileocecal (IC) junction (Fig. 5A and B). To determine the effect of losing three Pds5 alleles on ENS development we also examined the ENS in E12.5 Pds5A−/−;Pds5B+/− mice and found that they had slightly more extensive distal bowel aganglionosis than Pds5A−/− mice (Fig. 5A–D) suggesting that there is a Pds5 gene dosage effect on ENS development. To extend this observation we examined the ENS in Pds5A+/−;Pds5B−/− mice. Because most of these animals die at E11.5, the ENS analysis in these mice was performed at this early stage of development Remarkably, in Pds5A+/−;Pds5B−/− mice (n = 6) we observed very few enteric neurons distal to the stomach, suggesting severe migratory deficits in these mutant ENS precursor cells (Fig. 5E–H). To confirm that heterozygosity for Pds5A synergistically exacerbates the ENS defects caused by Pds5B-deficiency, we examined Pds5B−/− animals at this age and found abnormal, but less severe distal bowel aganglionosis. Collectively, these data demonstrate that both PDS5A and PDS5B have important roles in ENS development, but that PDS5B-deficiency causes more severe abnormalities than lack of PDS5A.
(A–C) Whole mount TuJ1 immunofluorescent antibody staining of E12.5 gut highlights the enteric neurons (A, Pds5A+/−; B, Pds5A−/−; C, Pds5A−/−;Pds5B+/−). White bars define the ileocecal junction and an asterisk denotes the end of the colon. Enteric neurons colonize the bowel to the mid-colon in wildtype mice (A), but migrate only to the proximal colon or ileocecal junction in Pds5A−/− (B) and to near the ileocecal junction in Pds5A−/−;Pds5B+/− mice (C). Scale bars: 10 µm. (D) Schematic representation of the extent of bowel colonization by enteric neurons Pds5A−/− mice at E12.5. [WT (n = 8), Pds5A−/− (n = 6), and Pds5A−/−;Pds5B+/− (n = 3)]. The scale at the top corresponds to the percentage of the respective intestinal segment (small or large intestine) successfully colonized by neurons. (E–G) Whole mount TuJ1 immunofluorescent antibody staining of E11.5 gut highlights the enteric neurons in (E) Pds5A+/−, (F) Pds5B−/− and (G) Pds5A+/−;Pds5B−/− mutant mice. White bars define the ileocecal junction and an asterisk denotes the end of the colon. Note that the enteric neuron migration wavefront in wildtype mice reaches the ileocecal junction at this age while migration was delayed in Pds5B−/− mice. In Pds5A−/−;Pds5B+/− mice only a few enteric neurons in the stomach were detected and none had migrated into the intestine. Scale bars: 10 µm. (H) Schematic representation of ENS defects in Pds5A+/−;Pds5B−/− mice at E11.5 [WT (n = 4), Pds5B−/− (n = 4), Pds5A+/−;Pds5B−/− (n = 6)]. The scale at the top corresponds to the percentage of the respective intestinal segment (small or large intestine) successfully colonized by neurons.
PDS5 proteins regulate lens development
In analyzing the E11.5 and E12.5 Pds5A−/−;Pds5B+/− and Pds5A+/−;Pds5B−/− embryos, we found a striking defect in lens development, either lens hypoplasia or agenesis (Fig. 6A–D, I, J), that was not observed in Pds5A- or Pds5B-deficient mice. Interestingly, Pds5A−/−;Pds5B+/− embryos frequently have lens agenesis, whereas Pds5A+/−;Pds5B−/− embryos usually have hypoplastic lenses. An immunohistochemical analysis revealed that PDS5A is highly expressed in head surface ectoderm at E9.5, a stage when the lens is beginning to form (Fig. 6E), whereas PDS5B expression was weak (data not shown). These results suggest that lens formation is more dependent on Pds5A, whereas Pds5B plays a more crucial role in ENS development.
(A, B) H&E stained sections of eyes from E12.5 wildtype and Pds5A−/−;Pds5B+/− embryos. No lens was formed in the Pds5A−/−;Pds5B+/− embryo (B), whereas the wildtype embryo has a clearly formed lens at this stage (A). (C,D) Whole mount image of the eyes from E11.5 wildtype and Pds5 mutant embryos. Note that the Pds5A+/−;Pds5B−/− eye (arrow, D) is much smaller than wildtype (white dashed circle, C). (E) Immunofluorescent staining of E9.5 eye using PDS5A antibodies demonstrated that PDS5A is expressed at high levels in head surface ectoderm. HSE, head surface ectoderm; M, mesenchyme; OV, optical vesicle; dashed lines, the boundaries among HSE, M, and OV. (F–H) Proliferating cells in the E10.5 eyes of wildtype (G) and Pds5A−/−;Pds5B+/− (H) embryos labeled with BrdU for 1 hr were detected using anti-BrdU antibodies. The eyes were counterstained with hematoxylin. Eye structures are as indicated in G. Note that the lens placode is invaginating in wildtype (G) but not in Pds5A−/−;Pds5B+/− embryos (H), although the percentage of BrdU positive cells in both wildtype and mutant lens placodes was equivalent (F). (I,J) Immunohistochemical analysis using αA-crystallin antibodies of E11.5 wildtype and Pds5A+/−;Pds5B−/− eyes. Note the small size and lack of αA-crystallin-positive cells in a Pds5A+/−;Pds5B−/− lens (J) compared to strong αA-crystallin expression in the majority of cells in a normal size, wildtype lens (I). R, retina; L, lens.
To further explore the mechanism of aberrant lens development, we performed a histological examination of E10.5 Pds5A−/−;Pds5B+/− embryos. This revealed diminished contact between the lens placode and optic vesicle (Fig. 6G and H), suggesting that PDS5 proteins are important for this initial contact and the lens induction that follows. Further morphological analysis showed that Pds5A−/−;Pds5B+/− mice had optic vesicles of normal thickness, but with a distorted shape (as seen in Fig. 6H). The peripheral regions of the lens placode were thinner than normal (data not shown) and fewer cells were present in this area. A BrdU labeling experiment however showed that the percentage of proliferating cells in the placode was similar in wildtype and Pds5A−/−;Pds5B+/− mice (Fig. 6F–H). These observations suggest that the abnormal shape of the optic vesicle resulted in decreased contact between it and the surface ectoderm, resulting in a smaller lens placode or failure of lens induction.
The developmental deficits caused by mutations in cohesin are likely due to changes in gene expression. To examine this possibility in the lens, we examined the expression of two transcription factors, Pax6 and Sox2, which regulate lens development. Immunostaining was performed on E9.5 and E10.5 eye sections; however no differences in expression were observed (data not shown). We next examined the expression of αA-crystallin, an abundant lens protein that serves as a marker for lens formation. We found that most cells in the hypoplastic Pds5A+/−;Pds5B−/− lens do not express αA-crystallin (Fig. 6I and J). These results suggest that PDS5 proteins help regulate αA-crystallin expression; however, its loss could also be due to aberrant post-transcriptional regulation or other indirect effects of PDS5 dysfunction. Nonetheless, the lens developmental abnormalities in Pds5-deficient mice provide a potential mechanism for how abnormal cohesin activity could cause the myopia associated with CdLS.
A PDS5B mutation that disrupts DNA-binding contributes to a familial case of CdLS with megacolon
Mutations affecting multiple cohesion factors, namely NIPBL, SMC1A, and SMC3 have been identified in CdLS patients, indicating that aberrant cohesin function is responsible for the anomalies associated with this syndrome. The discovery that Pds5B- and Pds5A-deficient mice exhibit developmental abnormalities resembling CdLS, prompted us to screen patients with CdLS for PDS5 mutations. We sequenced all exons of PDS5B and PDS5A and their adjacent intronic sequences that harbor splicing signals in 114 individuals with CdLS that had been screened previously for mutations in NIPBL, SMC1A and SMC3 (See Table S2 and S3 in Supplementary Data and Materials S1 for primer information). More than a dozen polymorphisms were detected in both PDS5A and PDS5B (See Fig. S7 and S8 in Supplementary Data and Materials S1). While no pathologic mutations in PDS5A were identified, we found one patient (CDL-238) with a G to A substitution in exon 32 of a single PDS5B allele that creates a missense mutation (R1292Q). This R1292Q substitution occurs at an evolutionarily conserved residue within the invariant core sequence (GRP) of the AT-hook DNA binding motif (Fig. 7A–C). This mutation was not present in 432 control chromosomes. The identification of only a single PDS5B mutation in this cohort of CdLS patients suggests that PDS5B mutations account for a very small portion of CdLS, a situation similar to that reported for SMC3 .
(A) A schematic diagram of PDS5B showing the location of the R1292Q mutation within the AT-hook domain. Red rectangles, HEAT repeats; grey rectangle, a leucine zipper domain; blue rectangles, AT-hook domains; thin black bars, phosphorylation sites (Ser, Thr, and Tyr) in the C-terminal region of PDS5B. Note: See additional PDS5B structural analysis in supplementary data (See Fig. S6 in Supplementary Data and Materials S1). (B) Sequencing traces displaying the G to A substitution (highlighted with an arrow) in one PDS5B allele in the proband (compare traces of proband and control). This substitution results in an Arg to Gln transition at PDS5B residue 1292. (C) Multispecies alignment of AT-hook domain from PDS5B and PDS5A. Note that the mutated Arg is highly conserved and located within the AT-hook domain. Hs, Homo sapiens; Pa, Pan troglodytes; Ca, Canis familiaris; Mm, Mus musculus; Rn, Rattus norvegicus; Ch, Gallus gallus; Xe, Xenopus tropicalis; Br, Danio rerio; Te, Tetraodon nigroviridis; Fu, Fugu rubripes. (D) The family tree of a proband (arrow) with three affected siblings (II-1,2,3, blackened circle or square), one clinically normal brother (II-4), and two clinically normal parents (I-1 and I-2). One of the affected siblings was deceased and no DNA was available from this individual (II-1). The father, two affected children, and one unaffected child carry the R1292Q mutation (depicted by blackened symbol or small black dot). (E) The PDS5B(R1292Q) mutant has decreased DNA binding. EMSA using the T5-8-T5 AT-rich probe showed decreased DNA binding by mutant PDS5B compared to wildtype PDS5B. The EMSA was performed with the indicated amounts of PDS5B protein (40, 20, 10, 5 ng). The specific nature of the binding was determined by EMSA competition assays (See Fig. S10 in Supplementary Data and Materials S1). Arrows, protein-DNA complexes. C, control.
The parents in the affected family are distantly consanguineous and three of their children were diagnosed with CdLS while one brother and both parents were clinically unaffected (Fig. 7D). We sequenced exon 32 in all available family members and found that two affected siblings (II-2 and II-3) carried the same mutation. In addition, the unaffected brother and the unaffected father also carried the mutation (I-1 and II-4, Fig. 7D). Another affected sibling (II-1) was deceased and no DNA was available. The affected family members showed a common combination of symptoms in the CdLS spectrum, including typical facial dysmorphisms (microbrachycephaly, arched eye brows, synophrys, ptosis, and long philtrum, low posterior hairline, short neck, See Fig. S9 in Supplementary Data and Materials S1), single palmar creases, hirsutism, mental retardation, seizures, and growth retardation (height and weight below the 3rd centiles). The hands were small, but no structural limb abnormalities were noted. In addition, two of the affected siblings (II-2 and II-3) have developed a severe form of megacolon, simlar to that observed in Goldberg-Shprintzen syndrome (OMIM#609460). This family therefore represents a familial CdLS case with atypical inheritance that includes associations with megacolon and mutation of the PDS5B gene. To further characterize the PDS5B inheritance in this family, we performed SNPs arrays. We found that the two affected siblings (II-2 and II-3) share the same maternal PDS5B allele, whereas the unaffected brother (II-4) inherited a different maternal PDS5B allele (See Table S4 in Supplementary Data and Materials S1). This result suggests that CdLS is transmitted in a recessive manner in this family and that a second mutation is likely to be present in the maternal PDS5B allele that was not detected by our sequence analysis.
The location of the R1292Q mutation within the AT-hook domain in PDS5B suggests that it could be functionally significant. The positively charged Arg within the core sequence of the AT-hook domain in high mobility group (HMG) proteins has been demonstrated by structural analysis and electrophoretic mobility shift assays (EMSA) to be crucial for DNA binding , . To test the effect of the R1292Q mutation on PDS5B function, we performed EMSA using the C-terminal region containing the AT-hook domains from both wildtype and R1292Q mutant PDS5B. As reported for the AT-hook containing HMG-1, we found that the PDS5B C-terminal region bound to the AT-rich DNA probe efficiently and specifically. However, the C-terminal region derived from PDS5B (R1292Q) had decreased DNA binding affinity (Fig. 7E and See Fig. S10 in Supplementary Data and Materials S1). Interestingly, we observed two DNA-protein complex bands on our EMSA assays (Fig. 7E and See Fig. S10 in Supplementary Data and Materials S1), suggesting that the two AT-hook motifs in PDS5B imbue it with multivalent binding properties like that of HMG-1 . While it has been previously speculated but never demonstrated that PDS5 can bind DNA , these results indicate that the R1292Q mutation disrupts the DNA binding affinity of the C-terminal PDS5B AT-hook domains. This presumably influences PDS5B-mediated transcriptional regulation, and may affect cohesin activity and development thus resulting in CdLS.
The cohesin complex mediates sister chromatid cohesion during cell division, regulates gene expression, and influences a broad spectrum of prenatal and postnatal developmental processes. In humans, subtle perturbations in cohesin activity contribute to disorders now known as ‘cohesinopathies’, such as CdLS and RBS, which are caused by mutations in NIPBL, SMC1A, SMC3, and ESCO2. While ∼50% of CdLS patients have identifiable mutations in NIPBL, mutations in other cohesion components (such as SMC1A and SMC3) appear to be much rarer (∼5%), leaving many clinically defined CdLS patients with no identified genetic lesion . We previously reported that mice deficient in Pds5B exhibit a spectrum of developmental defects reminiscent of those present in CdLS.
In this study, we sequenced the PDS5A and PDS5B genes in a cohort of CdLS patients and identified a mutation in a conserved motif (AT-hook domain) in PDS5B, which likely causes or contributes to the disease. Our analysis of PDS5B has identified two AT-hook domains  and a degenerative AT-hook domain in PDS5A (See Fig. S6 in Supplementary Data and Materials S1). We demonstrated that the PDS5B C-terminal region binds to an AT-rich DNA sequence motif similar to that recognized by HMG-1 , and that the CdLS-associated mutation in PDS5B at R1292Q decreases PDS5B DNA-binding affinity. The association of PDS5 with chromatin is dependent on functional cohesin in Hela cells and Xenopus egg extracts , suggesting that the PDS5B-DNA interactions demonstrated here may not be sufficient for recruitment of PDS5B to chromatin in vivo. Instead, PDS5B could interact with the cohesin core complex and modulate the subchromatin distribution of chromatin-loaded cohesin through its AT-hook domains. The acquisition of AT-hook domains in both PDS5A and PDS5B during evolution may therefore reflect the predilection of cohesin to interact with heterochromatin (i.e., AT-rich) chromosomal regions. The AT-hook motif can also interact with scaffold associated regions (SARs) ,  that can act as cis regulatory elements for SATB1 and SATB2, transcription factors that regulate skeletal patterning and palatogenesis , .
The functional mutation of PDS5B we identified in a familial CdLS case with atypical inheritance pattern is strongly suspected to be pathogenic, although further studies using mice expressing this mutant protein will be important in confirming its role in this syndrome. The occurrence of the mutation in unaffected family members has been previously demonstrated in one familial case of CdLS with an SMC1A mutation  and could be explained by three possibilities. First, the identification of a functional mutation in PDS5B and the segregation of maternal alleles in a disease-specific manner, as well as the recessive nature of the deficits in Pds5B mutant mice suggest that CdLS in this family is caused by compound heterozygosity of PDS5B mutations. In this case, the second PDS5B mutation could be a point mutation in an intron or in the regulatory region of PDS5B or other rearrangements like a deletion or translocation that would not be detected by sequencing.
A second possibility for the atypical genetic inheritance of PDS5B mutation in this family is dominant inheritance with incomplete penetrance. This is consistent with the variable expressivity and penetrance observed in Pds5B-deficient mice, suggesting that modifier genes or epigenetic factors contribute significantly to PDS5B-regulated development. Genetic or epigenetic modifers may be common in CdLS as there is significant phenotypic variability among patients with the same mutation, even within families –. In addition, the consanguinity of the parents may provide recessive inheritance of a modifier locus (or loci) whose homozygosity produces an environment whereby a single mutant PDS5B allele leads to developmental deficits.
Finally, it is possible that this represents a digenic pattern of inheritance. In this case, the other mutation could be present in other cohesin proteins that regulate PDS5B function. An example of such an inheritance pattern is Bardet-Biedl syndrome (BBS), a rare oligogenic disorder exhibiting genetic heterogeneity with primary cilium dysfunction . Like CdLS, the BBS phenotype is variable both between and within families. Interestingly, in some cases of BBS, mutations in two cilium genes are required for phenotypic penetrance . A similar situation exists for Hirschsprung disease, where hypomorphic mutations in both RET and endothelin can interact to cause the characteristic ENS deficits normally associated with heterozygous loss-of-function mutations in these genes .
Perhaps the most consistent and striking abnormalities in Pds5 mutant mice concern the aberrant migration of ENS precursors that results in intestinal hypoaganglionosis. This is not reported as part of the constellation of symptoms in CdLS, but could be related to the chronic constipation that is present in these patients . However, in this particular case these observations take on added interest as affected members of this family also develop severe megacolon. This disorder is similar to Hirschsprung disease, which is most often caused by mutations in the RET tyrosine kinase . These symptoms are consistent with the distal colon hypoganglionosis observed in Pds5B-deficient mice. This condition becomes more severe with decreasing Pds5 gene dosage, at which point it closely resembles deficits observed in Ret mutant mice . Interestingly, Ret-deficient mice also have deficits in sympathetic neurons that are similar to those present in Pds5B-deficient mice. Furthermore, cohesin mutations in zebrafish block expression of RUNX1, a transcription factor that regulates Ret expression in mammals . These findings suggest that Pds5B and Ret may act on similar pathways to regulate neuronal development. Indeed, the identification of PDS5B mutations in a family with CdLS and megacolon suggests that PDS5B could be a modifier for Hirschsprung disease and, that these two disorders may share additional molecular pathways.
Cohesin functions along with the chromatin insulator protein CTCF to regulate long-range enhancer-promoter communication-mediated gene expression, possibly through stabilizing CTCF-mediated chromosomal loops . These long-range effects on gene expression may be altered by defective cohesin function and ultimately be responsible for the developmental abnormalities present in CdLS and RBS. Cohesin and CTCF binding occurs at loci containing the Dlx5 and Bdnf genes , which encode proteins crucial for development of the skeleton and nervous system. Interestingly, cohesin and CTCF are bound to the Bdnf locus at several sites, including the promoter for isoform III, which is regulated by MeCP2 in a neuronal activity-dependent manner. Furthermore, the MeCP2-mediated expression of Dlx5 is dependent on changes in chromosomal looping , suggesting a potential mechanism by which mutations in cohesin components (e.g., in CdLS) could be translated into aberrant neuronal circuitry.
The Pds5A mutant mice have many developmental defects that are similar to those present in Pds5B-deficient mice and in humans with CdLS. Other phenotypes that are associated with Pds5B-deficient mice, like defects in the ENS discussed above as well as autonomic nervous system and primordial germ cell abnormalities were not present (or as severe) in Pds5A-deficient mice, suggesting both redundancy and/or diversification of the roles of PDS5 proteins during evolution. The broad spectrum of abnormalities with variable expressivity in Pds5A- and Pds5B-deficient mice is typical of CdLS , suggesting genetic, epigenetic or environmental factors can influence the effects of cohesin dysfunction. The striking phenotypes seen in these mice also suggest that additional human disorders with similar phenotypic overlap could be caused by mutations in PDS5A or PDS5B. Interestingly, the number of human diseases caused by mutations in cohesion proteins (cohesinopathies: CdLS, RBS/SC phocomelia, and Alpha thalassemia/mental retardation X linked (ATRX)), ,  is growing. The Pds5A- and Pds5B-deficient mice may be useful for the identification of genetic modifiers and genetic pathways critical for cohesin-regulated development that would constitute additional targets for mutational analysis in cohesinopathies.
Our inability to detect Pds5A;Pds5B double homozygous embryos indicates that PDS5 function is essential for early embryogenesis and may reflect its importance in mitosis or sister chromatid cohesion. While loss of either Pds5A or Pds5B caused neonatal lethality, the loss of three Pds5 alleles leads to mid-gestational embryonic death. Although these embryos showed striking defects in the enteric nervous system, heart, and lens, cells with only a single remaining Pds5 allele did not manifest precocious sister chromatid separation. These results suggest that a low level of PDS5 protein is sufficient for chromosome cohesion but is unable to sustain cohesin-mediated developmental gene expression. The differential sensitivities of developmental gene regulation and chromosome cohesion on cohesin dosage are corroborated by observations in other model organisms. In Drosophila, heterozygous mutants of either Nipped-B or Pds5 have decreased expression of the homeobox cut gene without cohesion abnormalities, whereas cohesion defects are present in the homozygous mutants . In zebrafish reduced cohesin levels lead to abnormal Runx1 expression, indicating that cohesin levels affect transcriptional regulation . Finally, in humans, heterozygous mutations in NIPBL, SMC1A, or SMC3 lead to CdLS, which is characterized by multiple developmental anomalies without overt cohesion defects . Although consistent with the hypothesis that perturbed non-canonical functions of cohesin are responsible for abnormalities present in cohesinopathies , , , the lack of cohesion defects in cells with low levels of PDS5 proteins is in contrast to PDS5 functions in budding yeast, C. elegans, and Drosophila. These organisms each contain a single PDS5 protein, and it plays a critical role in chromosome segregation , , . It should be noted, however, that only mild cohesion defects were found in Hela cells when either PDS5A or PDS5B were knocked down by RNAi ; again, suggesting that low amounts of PDS5 protein are sufficient to support cohesion.
In summary, we have discovered that PDS5B is mutated in a familial case of CdLS with megacolon, and that PDS5A and PDS5B have both redundant and distinct roles in development that are likely unrelated to its ancient function in sister chromatid cohesion. The Pds5A- and Pds5B-deficient mice provide valuable mammalian models to study molecular mechanisms of developmental functions of the cohesin complex and the pathogenesis of cohesinopathies.
Materials and Methods
All subjects enrolled in this study were consented under an IRB-approved protocol of informed consent through The Children's Hospital of Philadelphia. All consents were written and signed by the participants or by their parents or guardians in the case of minors. All mouse experiments were performed under protocols approved by the Washington University Animal Studies Committee.
Re-sequencing of PDS5B and PDS5A
All subjects were evaluated by one or more clinical dysmorphologists with experience with CdLS patients (supervised by Ian Krantz, U. Penn). All of these samples were pre-screened by investigators at U. Penn and found to have no mutations in NIPBL, SMC1A, and SMC3 , , thus they have unidentified genetic alterations.
Using primer design software (Primer3), amplification primers for each exon of PDS5B (36 exons) and PDS5A (33 exons) were designed so that the intron-exon junctions as well as the entire exon were sequenced in both directions (Tables S1 and S2)). Forward primers contain M13 forward sequence at the 5′ end and reverse primers contain M13 reverse sequence at the 5′ end so that each amplicon could be sequenced with the universal M13 forward and reverse sequencing primers. Primers were ‘validated’ in a trial PCR reaction using control DNA to ensure that a single fragment of predicted size was obtained. If a primer set failed to amplify the anticipated product, new primers were designed for the failed amplicon, and the process was repeated until specific amplicons were obtained. The sequencing traces were analyzed in Mutation Viewer (MV, bioinformatics core of Washington University in St. Louis), and ‘high confidence’ sequence alterations that did not coincide to polymorphisms present in SNP databases were verified by examining the sequence traces directly. Alterations that were clearly present were confirmed by re-amplifying and sequencing the suspect amplicons.
Purification of Recombinant C-terminal PDS5B and Electrophoretic Mobility Shift Assays
C-terminal human PDS5B (a.a. sequence: 1134–1446, either wildtype or R1292Q mutant) was amplified by PCR using primers (forward primer: 5′-GCTAGTCATATGTACCCGTACGACGTCCCGGACTACGCTTCTGAATTGGAGAAGCCTAGAGGCA-3′ and reverse primer: 5′-GCTAGTAAGCTTTCGCCGTTCCCTTTTAGCACT-3′) and an N-terminal HA tag was introduced. This fragment was cloned into the pET30a(+) vector so that it also contained a C-terminal 6xHis tag. BL21 Rosetta cells (Novagen) were transformed with this HA and 6xHis tagged C-terminal PDS5B pET30a(+) vector and grown to mid-log phase (OD600 = 0.6). Protein expression was induced by addition of isopropyl-β-D-thiogalactopyranoside (final conc. = 150 µM) and the bacterial cells were lysed 2 hr later using the cell lytic kit (Sigma). His-tagged PDS5B fusion proteins were purified on nickel-nitrilotriacetic acid columns (Sigma). Eluted proteins were concentrated using Amicon columns (Millipore), and the concentration was determined using the BCA protein assays (Pierce), equalized by dilution, and dialyzed against Buffer A (50 mM Tris, pH 7.5, 0.5 mM EDTA, 100 mM NaCl, 10% glycerol, 1 mM dithiothreitol) overnight. Electrophoretic Mobility Shift Assays (EMSA) were performed as previously described . Briefly, 20 ng of purified protein was mixed with 2.25 pmol of 32P-labeled double-stranded oligonucleotide probe (∼30,000 cpm, T5-8- T5) and incubated at 25°C for 5 min. The mixture was electrophoresed through a 6% polyacrylamide gel and the shifted fragments were visualized by autoradiography. Sequences of the oligonucleotides used to make the T5-8-T5 DNA probes are: 5′-GGACTCCAGGTCCAGGACCGCTTTTTGCGCGCGCTTTTTGCGGGAGGTCCAGCTGTCCACCTCC-3′ and 5′-GGAGGTGGACAGCTGGACCTCCCGCAAAAAGCGCGCGCAAAAAGCGGTCCTGGACCTGGAGTCC-3′.
Immunohistochemistry and Western blot analysis
Tissues used in immunohistochemistry were fixed in paraformaldehyde/Bouin's fixative. For antigen retrieval, paraffin-embedded sections were de-paraffinized in xylene, hydrated and boiled in 1 mM EDTA solution for 30 min prior to immunostaining . Primary antibodies used in this study include sheep anti-tyrosine hydroxylase (1∶200; Chemicon), anti-αA-crystallin (1∶500; antibody kindly provided by Usha Andley from hybridoma cells isolated by Paul FitzGerald), and rabbit anti-PDS5A (1∶1,000; Bethyl Laboratories, Montgomery, TX). The signals were visualized using donkey anti-sheep HRP (1∶200; Jackson immunoresearch), donkey anti-mouse HRP (1∶100, Jackson immunoresearch), or goat anti-rabbit Cy3 (1∶500; Jackson ImmunoResearch) secondary antibodies.
Western blot analysis was performed using standard techniques and proteins derived from E18.5 kidney. The kidneys were homogenized in 2× SDS protein lysis buffer (100 mM Tris-HCl, pH 6.8, 4% SDS, 1× protease inhibitor cocktail (Roche)) and 40 µg of total protein was loaded onto the gel. The blots were probed with rabbit anti-PDS5A antibody (1∶10,000 dilution; Bethyl Laboratories, Montgomery, TX), mouse monoclonal anti-β-galactosidase (1∶1000 dilution, from Roche), or rabbit anti-SMC3 antibody (1∶1000 dilution; kindly provided by Rolf Jessberger from Dresden University of Technology). The signals were visualized using species-specific HRP conjugated secondary antibodies and chemiluminescence substrate (Pierce). For a loading control, mouse anti-β-tubulin antibody (DSHB, University of Iowa, IA) was also used at 1∶20,000 dilution.
Histological analysis of bone and palate
Alizarin Red S and Alcian Blue staining of newborn mice was performed as previously described . Briefly, newborn mice were de-skinned and dehydrated in 95% EtOH. They were then stained in Alcian blue solution for 3 d, rehydrated and incubated in 1% KOH for 2 d, and stained for Alizarin Red S for 3 d. For embryonic and newborn heads, fixation was carried out in 4% paraformaldehyde at 4°C for 16 h. The fixed heads were properly oriented in paraffin and coronal sections were prepared. The sections were stained with Hematoxylin and Eosin (H & E) and examined microscopically for evidence of cleft palate.
Analysis of germ cells, testes transplantation, and the renal system
Embryonic gonads were dissected, fixed in Bouin's solution overnight at 4°C, embedded in paraffin, and 6 µm sections were prepared. Germ cells were examined by H&E staining.
Testes from E18.5 mutant and wild-type mice were transplanted subcutaneously onto the back/flank of castrated 4- to 8-wk-old male nude mice (Taconic #NCRNUM, Germantown, NY) as previously described . The grafted donor testes were harvested and processed for histological evaluation at the indicated time points. To determine relative nephron numbers, we serially sectioned E18.5 kidneys in their entirety and counted glomeruli every 120 µm .
Analysis of cardiac malformations
The E12.5, E18.5, or newborn thorax was fixed in 4% formaldehyde before the entire thorax or dissected heart was embedded in paraffin. The tissue blocks were serially sectioned completely at 6 µm thickness, hematoxylin and eosin stained, and inspected for defects .
Nervous system analysis of Pds5 mutant mice
Dissociated hippocampal neurons from E15 mouse embryos were cultured in Neurobasal medium with B27 (Invitrogen). The anti-mitotic reagent, 5-Fluoro-2′-deoxyuridine (FDU) (Sigma #F0503), was used at a final concentration of 20 µM for the first three days of culture to eliminate proliferating, nonneuronal cells. To study polarity, neuronal morphology was analyzed at 3 DIV by immunostaining with neuronal-specific beta III tubulin (TuJ1) (Covance) antibody. Neurons bearing only a single long axon, indicative of normal neuronal polarization, were counted. The neurons were stained with tau-1 antibody to confirm the neuronal processes were axons.
For analysis of the enteric nervous system, E11.5 or E12.5 gut was dissected from the mouse, fixed with 4% paraformaldehyde at 25°C for 30 min, and stained as a whole mount with TuJ1 antibody. The sympathetic nervous system was analyzed using whole-mount TOH immunohistochemistry as described previously .
Analysis of lens development
The heads of E9.5 to E12.5 embryos were fixed in 4% paraformaldehyde and embedded in paraffin with a specified orientation for all specimens. Serial sections were stained with H & E for microscopic examination. For BrdU immunostaining, timed pregnant females were injected with 50 mg/kg body weight of a mixture of 10 mM BrdU (Roche, Indianapolis, IN) and 1 mM 5-fluoro-5-deoxyuridine (Sigma, St. Louis, MO) and sacrificed after 1 hour. Paraffin-embedded sections of embryonic head were incubated with a monoclonal anti-BrdU antibody (1∶250, Dako, Carpinteria, CA) and visualized with a Vectastain Elite Mouse IgG ABC kit (Dako, Carpinteria, CA).
Metaphase spread analysis of mouse embryonic fibroblast cells
Chromosome analysis was performed in the cytogenetics core at Washington University Medical School. Mouse embryonic fibroblasts from wildtype, Pds5A, Pds5A+/−;Pds5B−/−, Pds5A−/−;Pds5B+/− or Pds5B mutant mice (passage 1–3) were cultured in DMEM with 10% fetal bovine serum. Chromosomes were harvested the day after plating after growth in colcemid (1 ug/ml) for 1 h using standard hypotonic (0.075 M KCl) treatment and fixation in methanol-acetic acid (3∶1). Slides were prepared and chromosomes were analyzed using the GTG (giemsa-banding using trypsin and giemsa) banding method. More than two cell lines were analyzed for each genotype. More than two cells were fully analyzed from each line, and all were found to have normal karyotypes. More than fifty cells were examined for precocious sister chromatid separation (PSCS) for each line.
Fluorescence recovery after photobleaching (FRAP) analysis of SCC1-EGFP
The SCC1 cDNA was released from pEGFP-N1-SCC1 (gift from Cryns VL; ) by digestion with BglII and AgeI and inserted into the BamHI and AgeI sites of FUGW (gift from Baltimore D; ) to generate the SCC1-EGFP fusion construct in lentivirus vector (named FU-SCC1-EGFP). Lentivirus expressing SCC1-EGFP was made by standard methods with a titer of 106 to 107 infectious particles per mL. MEF cells were infected with lentivirus for 12 hr followed by two washes with medium to remove remaining virus. Three days after infection, MEF cells were cultured on Lab-Tek Chambered CoverGlasses slides (Nunc) with CO2-independent medium (Invitrogen) for FRAP. Half of the nucleus was repeatedly bleached using a Leica SP5 confocal microscope equipped with a 60×1.4 oil immersion objective at high laser power with a 6–8× zoom. The fluorescence intensity was measured every 30 sec for 30 min post-bleaching with the laser on low power. The difference in fluorescence between the unbleached and bleached regions over time was calculated to generate the re-equilibration curve. The fraction of weak vs. strong chromatin bound SCC1-EGFP as well as their residence times were calculated using bi-exponential function fitting as described . Unbound/soluble and chromatin-bound fractions were determined by comparing the SCC1-EGFP fluorescences of unbleached half nuclei before photobleaching and at t = 0 s after photobleaching, when nuclear-localized soluble EGFP that cannot bind chromosomes gets completely bleached (Dorsett D, personal communication). Re-equilibration curves incorporating data from t = 0 s after photobleaching and bi-exponential function fitting contribute to the detection of weak chromatin-bound SCC1 component, which has not been detected before . MEFs cannot be synchronized, so we were unable to detect the differences in SCC1-chromatin association dynamics in G1 vs. G2 cells in these FRAP assays.
We thank Shelly Audrain, Jennifer Stratman, Tim Fahrner, Kelli Simburger, Amber Nielson, Jack Shields, Jennifer Armon, Amy Strickland, Amanda Knoten, Tatiana Gorodinsky, Nina Panchenko, and Sandra Crocker for technical assistance. We are grateful to Rakesh Nagarajan and Mark Watson for their assistance on the application of Mutation Viewer.
Conceived and designed the experiments: BZ JM. Performed the experiments: BZ JC MF JH RK. Analyzed the data: BZ ES SJ KS MAD DD DCB PYJ ROH IK. Contributed reagents/materials/analysis tools: BZ MLGU IK. Wrote the paper: BZ JM.
- 1. Jackson L, Kline AD, Barr MA, Koch S (1993) de Lange syndrome: a clinical review of 310 individuals. Am J Med Genet 47: 940–946.
- 2. Krantz ID, McCallum J, DeScipio C, Kaur M, Gillis LA, et al. (2004) Cornelia de Lange syndrome is caused by mutations in NIPBL, the human homolog of Drosophila melanogaster Nipped-B. Nat Genet 36: 631–635.
- 3. Tonkin ET, Wang TJ, Lisgo S, Bamshad MJ, Strachan T (2004) NIPBL, encoding a homolog of fungal Scc2-type sister chromatid cohesion proteins and fly Nipped-B, is mutated in Cornelia de Lange syndrome. Nat Genet 36: 636–641.
- 4. Deardorff MA, Kaur M, Yaeger D, Rampuria A, Korolev S, et al. (2007) Mutations in cohesin complex members SMC3 and SMC1A cause a mild variant of cornelia de Lange syndrome with predominant mental retardation. Am J Hum Genet 80: 485–494.
- 5. Vega H, Waisfisz Q, Gordillo M, Sakai N, Yanagihara I, et al. (2005) Roberts syndrome is caused by mutations in ESCO2, a human homolog of yeast ECO1 that is essential for the establishment of sister chromatid cohesion. Nat Genet 37: 468–470.
- 6. Schule B, Oviedo A, Johnston K, Pai S, Francke U (2005) Inactivating mutations in ESCO2 cause SC phocomelia and Roberts syndrome: no phenotype-genotype correlation. Am J Hum Genet 77: 1117–1128.
- 7. Russell KL, Ming JE, Patel K, Jukofsky L, Magnusson M, et al. (2001) Dominant paternal transmission of Cornelia de Lange syndrome: a new case and review of 25 previously reported familial recurrences. Am J Med Genet 104: 267–276.
- 8. Musio A, Selicorni A, Focarelli ML, Gervasini C, Milani D, et al. (2006) X-linked Cornelia de Lange syndrome owing to SMC1L1 mutations. Nat Genet 38: 528–530.
- 9. Robinson LK, Wolfsberg E, Jones KL (1985) Brachmann-de Lange syndrome: evidence for autosomal dominant inheritance. Am J Med Genet 22: 109–115.
- 10. Kozma C (1996) Autosomal dominant inheritance of Brachmann-de Lange syndrome. Am J Med Genet 66: 445–448.
- 11. Gillis LA, McCallum J, Kaur M, DeScipio C, Yaeger D, et al. (2004) NIPBL mutational analysis in 120 individuals with Cornelia de Lange syndrome and evaluation of genotype-phenotype correlations. Am J Hum Genet 75: 610–623.
- 12. Lalatta F, Russo S, Gentilin B, Spaccini L, Boschetto C, et al. (2007) Prenatal/neonatal pathology in two cases of Cornelia de Lange syndrome harboring novel mutations of NIPBL. Genet Med 9: 188–194.
- 13. Hartman T, Stead K, Koshland D, Guacci V (2000) Pds5p is an essential chromosomal protein required for both sister chromatid cohesion and condensation in Saccharomyces cerevisiae. J Cell Biol 151: 613–626.
- 14. Nasmyth K, Haering CH (2005) The structure and function of SMC and kleisin complexes. Annu Rev Biochem 74: 595–648.
- 15. Skibbens RV, Corson LB, Koshland D, Hieter P (1999) Ctf7p is essential for sister chromatid cohesion and links mitotic chromosome structure to the DNA replication machinery. Genes Dev 13: 307–319.
- 16. Kueng S, Hegemann B, Peters BH, Lipp JJ, Schleiffer A, et al. (2006) Wapl controls the dynamic association of cohesin with chromatin. Cell 127: 955–967.
- 17. Chen F, Kamradt M, Mulcahy M, Byun Y, Xu H, et al. (2002) Caspase proteolysis of the cohesin component RAD21 promotes apoptosis. J Biol Chem 277: 16775–16781.
- 18. Benard CY, Kebir H, Takagi S, Hekimi S (2004) mau-2 acts cell-autonomously to guide axonal migrations in Caenorhabditis elegans. Development 131: 5947–5958.
- 19. Seitan VC, Banks P, Laval S, Majid NA, Dorsett D, et al. (2006) Metazoan Scc4 Homologs Link Sister Chromatid Cohesion to Cell and Axon Migration Guidance. PLoS Biol 4: e242.
- 20. Horsfield JA, Anagnostou SH, Hu JK, Cho KH, Geisler R, et al. (2007) Cohesin-dependent regulation of Runx genes. Development 134: 2639–2649.
- 21. Dorsett D, Eissenberg JC, Misulovin Z, Martens A, Redding B, McKim K (2005) Effects of sister chromatid cohesion proteins on cut gene expression during wing development in Drosophila. Development 132: 4743–4753.
- 22. Zhang B, Jain S, Song H, Fu M, Heuckeroth RO, et al. (2007) Mice lacking sister chromatid cohesion protein PDS5B exhibit developmental abnormalities reminiscent of Cornelia de Lange syndrome. Development 134: 3191–3201.
- 23. Wendt KS, Yoshida K, Itoh T, Bando M, Koch B, et al. (2008) Cohesin mediates transcriptional insulation by CCCTC-binding factor. Nature 451: 796–801.
- 24. Schuldiner O, Berdnik D, Levy JM, Wu JS, Luginbuhl D, et al. (2008) piggyBac-based mosaic screen identifies a postmitotic function for cohesin in regulating developmental axon pruning. Dev Cell 14: 227–238.
- 25. Pauli A, Althoff F, Oliveira RA, Heidmann S, Schuldiner O, et al. (2008) Cell-type-specific TEV protease cleavage reveals cohesin functions in Drosophila neurons. Dev Cell 14: 239–251.
- 26. Dorsett D (1999) Distant liaisons: long-range enhancer-promoter interactions in Drosophila. Curr Opin Genet Dev 9: 505–514.
- 27. Misulovin Z, Schwartz YB, Li XY, Kahn TG, Gause M, et al. (2007) Association of cohesin and Nipped-B with transcriptionally active regions of the Drosophila melanogaster genome. Chromosoma.
- 28. Parelho V, Hadjur S, Spivakov M, Leleu M, Sauer S, et al. (2008) Cohesins functionally associate with CTCF on mammalian chromosome arms. Cell 132: 422–433.
- 29. Haering CH, Farcas AM, Arumugam P, Metson J, Nasmyth K (2008) The cohesin ring concatenates sister DNA molecules. Nature 454: 297–301.
- 30. Losada A, Yokochi T, Hirano T (2005) Functional contribution of Pds5 to cohesin-mediated cohesion in human cells and Xenopus egg extracts. J Cell Sci 118: 2133–2141.
- 31. Tanaka K, Hao Z, Kai M, Okayama H (2001) Establishment and maintenance of sister chromatid cohesion in fission yeast by a unique mechanism. Embo J 20: 5779–5790.
- 32. Ivanov D, Schleiffer A, Eisenhaber F, Mechtler K, Haering CH, et al. (2002) Eco1 is a novel acetyltransferase that can acetylate proteins involved in cohesion. Curr Biol 12: 323–328.
- 33. Kumar D, Sakabe I, Patel S, Zhang Y, Ahmad I, et al. (2004) SCC-112, a novel cell cycle-regulated molecule, exhibits reduced expression in human renal carcinomas. Gene 328: 187–196.
- 34. Ptacek LJ, Opitz JM, Smith DW, Gerritsen T, Waisman HA (1963) The Cornelia De Lange Syndrome. J Pediatr 63: 1000–1020.
- 35. Gerlich D, Koch B, Dupeux F, Peters JM, Ellenberg J (2006) Live-cell imaging reveals a stable cohesin-chromatin interaction after but not before DNA replication. Curr Biol 16: 1571–1578.
- 36. Mehta AV, Ambalavanan SK (1997) Occurrence of congenital heart disease in children with Brachmann-de Lange syndrome. Am J Med Genet 71: 434–435.
- 37. Wan LB, Pan H, Hannenhalli S, Cheng Y, Ma J, et al. (2008) Maternal depletion of CTCF reveals multiple functions during oocyte and preimplantation embryo development. Development 135: 2729–2738.
- 38. Hutson MR, Kirby ML (2007) Model systems for the study of heart development and disease. Cardiac neural crest and conotruncal malformations. Seminars in cell & developmental biology 18: 101–110.
- 39. Metcalf CE, Wassarman DA (2006) DNA binding properties of TAF1 isoforms with two AT-hooks. J Biol Chem 281: 30015–30023.
- 40. Huth JR, Bewley CA, Nissen MS, Evans JN, Reeves R, et al. (1997) The solution structure of an HMG-I(Y)-DNA complex defines a new architectural minor groove binding motif. Nature structural biology 4: 657–665.
- 41. Maher JF, Nathans D (1996) Multivalent DNA-binding properties of the HMG-1 proteins. Proc Natl Acad Sci U S A 93: 6716–6720.
- 42. Panizza S, Tanaka T, Hochwagen A, Eisenhaber F, Nasmyth K (2000) Pds5 cooperates with cohesin in maintaining sister chromatid cohesion. Curr Biol 10: 1557–1564.
- 43. Khadake JR, Rao MR (1997) Preferential condensation of SAR-DNA by histone H1 and its SPKK containing octapeptide repeat motif. FEBS Lett 400: 193–196.
- 44. Broeker PL, Harden A, Rowley JD, Zeleznik-Le N (1996) The mixed lineage leukemia (MLL) protein involved in 11q23 translocations contains a domain that binds cruciform DNA and scaffold attachment region (SAR) DNA. Curr Top Microbiol Immunol 211: 259–268.
- 45. Dobreva G, Chahrour M, Dautzenberg M, Chirivella L, Kanzler B, et al. (2006) SATB2 is a multifunctional determinant of craniofacial patterning and osteoblast differentiation. Cell 125: 971–986.
- 46. FitzPatrick DR, Carr IM, McLaren L, Leek JP, Wightman P, et al. (2003) Identification of SATB2 as the cleft palate gene on 2q32–q33. Hum Mol Genet 12: 2491–2501.
- 47. Ansley SJ, Badano JL, Blacque OE, Hill J, Hoskins BE, et al. (2003) Basal body dysfunction is a likely cause of pleiotropic Bardet-Biedl syndrome. Nature 425: 628–633.
- 48. Katsanis N, Ansley SJ, Badano JL, Eichers ER, Lewis RA, et al. (2001) Triallelic inheritance in Bardet-Biedl syndrome, a Mendelian recessive disorder. Science 293: 2256–2259.
- 49. Auricchio A, Griseri P, Carpentieri ML, Betsos N, Staiano A, et al. (1999) Double heterozygosity for a RET substitution interfering with splicing and an EDNRB missense mutation in Hirschsprung disease. Am J Hum Genet 64: 1216–1221.
- 50. Kline AD, Grados M, Sponseller P, Levy HP, Blagowidow N, et al. (2007) Natural history of aging in Cornelia de Lange syndrome. American journal of medical genetics 145C: 248–260.
- 51. Angrist M, Bolk S, Thiel B, Puffenberger EG, Hofstra RM, et al. (1995) Mutation analysis of the RET receptor tyrosine kinase in Hirschsprung disease. Hum Mol Genet 4: 821–830.
- 52. Jain S, Naughton CK, Yang M, Strickland A, Vij K, et al. (2004) Mice expressing a dominant-negative Ret mutation phenocopy human Hirschsprung disease and delineate a direct role of Ret in spermatogenesis. Development 131: 5503–5513.
- 53. Gause M, Schaaf CA, Dorsett D (2008) Cohesin and CTCF: cooperating to control chromosome conformation? Bioessays 30: 715–718.
- 54. Horike S, Cai S, Miyano M, Cheng JF, Kohwi-Shigematsu T (2005) Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome. Nat Genet 37: 31–40.
- 55. Ritchie K, Seah C, Moulin J, Isaac C, Dick F, et al. (2008) Loss of ATRX leads to chromosome cohesion and congression defects. J Cell Biol 180: 315–324.
- 56. Dorsett D (2006) Roles of the sister chromatid cohesion apparatus in gene expression, development, and human syndromes. Chromosoma.
- 57. Wang F, Yoder J, Antoshechkin I, Han M (2003) Caenorhabditis elegans EVL-14/PDS-5 and SCC-3 are essential for sister chromatid cohesion in meiosis and mitosis. Mol Cell Biol 23: 7698–7707.
- 58. Honaramooz A, Snedaker A, Boiani M, Scholer H, Dobrinski I, et al. (2002) Sperm from neonatal mammalian testes grafted in mice. Nature 418: 778–781.
- 59. Lois C, Hong EJ, Pease S, Brown EJ, Baltimore D (2002) Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 295: 868–872.